Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 11Leukemia 10Myelodysplastic Syndromes 9Congenital Abnormalities 9Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic-Phase 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myeloproliferative Disorders 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Anemia, Refractory, with Excess of Blasts 4Thrombocythemia, Essential 3Polycythemia Vera 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Erythroblastic, Acute 3Blast Crisis 3Primary Myelofibrosis 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Prolymphocytic 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Large Granular Lymphocytic 2Chromosome 5q Deletion Syndrome 2

Interventions

fludarabine phosphate 18Cyclophosphamide 18Peripheral Blood Stem Cell Transplantation 17Busulfan 17Tacrolimus 14Methotrexate 14Mycophenolic Acid 12Antilymphocyte Serum 12Cyclosporine 11Whole-Body Irradiation 9Flow Cytometry 9Filgrastim 7Etoposide 7Radiotherapy 6Methylprednisolone 6Melphalan 6Cord Blood Stem Cell Transplantation 6Therapeutics 5Psychiatric Rehabilitation 5Polymerase Chain Reaction 5Sirolimus 4Immunoenzyme Techniques 4thymoglobulin 3Rituximab 3Ondansetron 3Immunologic Techniques 3Early Intervention, Educational 3Cytarabine 3Cyclosporins 3Aprepitant 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pdgfra-Associated Chronic Eosinophilic Leukemia × Cytogenetic Analysis × Myeloid × Clear all
NCT00816413 2023-08-14

Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

University of Nebraska

Phase 1/2 Withdrawn
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Aplastic, Blast Crisis, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡